✦ LIBER ✦

Long-Term Safety and Efficacy of Mipomersen in Patients with Familial Hypercholesterolemia Uncontrolled by Maximally Tolerated Lipid Lowering Therapy

✍ Scribed by P. Barton Duell; Raul D. Santos; Cara East; John R. Guyton; Patrick M. Moriarty; Joanne M. Donovan; Robert S. Mittleman

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Long-term safety and efficacy of high-do

✍ Sanne van Wissen; Tineke J. Smilde; Mieke D. Trip; Anton F.H. Stalenhoef; John J 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 100 KB

Long Term Efficacy and Safety of Mipomer

✍ Duell, P. Bart; Rose, J.E.; Selvey, S.; Alam, Shushama; Mittleman, R. 📂 Article 📅 2013 🏛 Elsevier 🌐 English ⚖ 42 KB

PM385 Safety, Tolerability, And Efficacy

✍ Raal, Frederick; Nelson, Patric; Langslet, Gisle; Basart, Dick C.G.; Civeira, Fe 📂 Article 📅 2014 🏛 Elsevier 🌐 English ⚖ 155 KB

Efficacy and Safety of Alirocumab in Pat

✍ Kastelein, John J. P.; Robinson, Jennifer G.; Farnier, Michel; Krempf, Michel; L 📂 Article 📅 2014 🏛 Springer US 🌐 English ⚖ 293 KB

Lipid-Altering Efficacy and Safety of Si

✍ Leiv Ose; Michael H. Davidson; William Insull; Mei Wu; Ann C. Tate; Michael R. M 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 930 KB

M.571 Evaluation of the long-term safety

✍ Lipka, L.; Ballantyne, C.; Sager, P.; Strony, J.; Alizadeh, J.; Suresh, R.; Velt 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 139 KB